Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically

被引:24
作者
Yang, Bin [1 ]
Xia, Haizhui [1 ]
Xu, Chuxiao [1 ]
Lu, Min [2 ]
Zhang, Shudong [1 ]
Wang, Guoliang [1 ]
Ma, Lulin [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Urol, 49 North Garden Rd, Beijing 100191, Peoples R China
[2] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing, Peoples R China
关键词
Sarcomatoid; Rhabdoid; Renal cell carcinoma; Vena cava; Thrombus; Prognosis; CANCER-SPECIFIC SURVIVAL; HISTOLOGIC SUBTYPE; OUTCOMES; CLASSIFICATION; NEPHRECTOMY; SYSTEM;
D O I
10.1186/s12894-020-0584-z
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Sarcomatoid differentiation in renal cell carcinoma (RCC) with vena caval tumour thrombus has been shown to be associated with aggressive behaviours and poor prognosis; however, evidence of the impact of rhabdoid differentiation on prognosis is lacking. This study evaluated the impact of sarcomatoid differentiation and rhabdoid differentiation on oncological outcomes for RCC with vena caval tumour thrombus treated surgically. Methods We retrospectively analysed patients treated surgically for RCC with vena caval tumour thrombus at our institute from Jan 2015 to Nov 2018. Prognostic variables were evaluated for associations with progression-free survival (PFS) and cancer-specific survival (CSS) by Kaplan-Meier survival analysis and log-rank test. Univariate and multivariate analyses were performed to determine independent prognostic variables. Results We identified 125 patients with RCC and vena caval tumour thrombus, including 17 (13.6%) with sarcomatoid differentiation alone, 8 (6.4%) with rhabdoid differentiation alone and 3 (2.4%) with both sarcomatoid and rhabdoid differentiation. Compared to pure RCC, patients with sarcomatoid differentiation but not rhabdoid differentiation have worse PFS (p = 0.018 and p = 0.095, respectively). The univariate and multivariate analyses both showed sarcomatoid differentiation as a significant predictor of PFS. Compared to pure RCC, patients with sarcomatoid differentiation (p = 0.002) and rhabdoid differentiation (p = 0.001) both had significantly worse CSS. The univariate analysis showed sarcomatoid differentiation, rhabdoid differentiation, metastasis and blood transfusion as significant predictors of CSS (All, p < 0.05). In the multivariate analysis, sarcomatoid differentiation (HR 3.90, p = 0.008), rhabdoid differentiation (HR 3.01, p = 0.042), metastasis (HR 3.87, p = 0.004) and blood transfusion (HR 1.34, p = 0.041) all remained independent predictors of CSS. Conclusions Sarcomatoid differentiation and rhabdoid differentiation are both independent predictors of poor prognosis in RCC with vena caval tumour thrombus treated surgically.
引用
收藏
页数:8
相关论文
共 30 条
[1]   Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus [J].
Abel, E. Jason ;
Spiess, Philippe E. ;
Margulis, Vitaly ;
Master, Viraj A. ;
Mann, Michael ;
Zargar-Shoshtari, Kamran ;
Borregales, Leonardo D. ;
Sexton, Wade J. ;
Patil, Datta ;
Matin, Surena F. ;
Wood, Christopher G. ;
Karam, Jose A. .
JOURNAL OF UROLOGY, 2017, 198 (02) :281-288
[2]   Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation [J].
Adibi, Mehrad ;
Thomas, Arun Z. ;
Borregales, Leonardo D. ;
Merrill, Megan M. ;
Slack, Rebecca S. ;
Chen, Hsiang-Chun ;
Sircar, Kanishka ;
Murugan, Paari ;
Tamboli, Pheroze ;
Jonasch, Eric ;
Tannir, Nizar M. ;
Matin, Surena F. ;
Wood, Christopher G. ;
Karam, Jose A. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (10) :427.e17-427.e23
[3]   Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the Tree [J].
Bergerot, Paulo ;
Agarwal, Neeraj ;
Pal, Sumanta K. ;
Jones, Jeremy .
CLINICAL CANCER RESEARCH, 2017, 23 (21) :6381-6383
[4]   The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus [J].
Blute, ML ;
Leibovich, BC ;
Lohse, CM ;
Cheville, JC ;
Zincke, H .
BJU INTERNATIONAL, 2004, 94 (01) :33-41
[5]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[6]   Sarcomatoid renal cell carcinoma - An examination of underlying histologic subtype and an analysis of associations with patient outcome [J].
Cheville, JC ;
Lohse, CM ;
Zincke, H ;
Weaver, AL ;
Leibovich, BC ;
Frank, I ;
Blute, ML .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (04) :435-441
[7]   Sarcomatoid renal carcinoma: The final common dedifferentiation pathway of renal epithelial malignancies [J].
Delahunt, B .
PATHOLOGY, 1999, 31 (03) :185-190
[8]   Grading of renal cell carcinoma [J].
Delahunt, Brett ;
Eble, John N. ;
Egevad, Lars ;
Samaratunga, Hemamali .
HISTOPATHOLOGY, 2019, 74 (01) :4-17
[9]   A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis [J].
Delahunt, Brett ;
McKenney, Jesse K. ;
Lohse, Christine M. ;
Leibovich, Bradley C. ;
Thompson, Robert Houston ;
Boorjian, Stephen A. ;
Cheville, John C. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (03) :311-322
[10]   Sarcomatoid renal cell carcinoma: Biology and treatment advances [J].
El Mouallem, Nemer ;
Smith, Steven C. ;
Paul, Asit K. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) :265-271